ProCE Banner Activity

Current Status and European Perspective on the Application of Actionable Biomarkers for Ovarian and Endometrial Cancers

Conference Coverage
Clinical Thought

Read this commentary from Prof Isabelle Ray-Coquard, MD, PhD, and Bernard Doger de Spéville, MD, PhD, on the current status and application of actionable biomarkers for ovarian and endometrial cancers in Europe.

This ClinicalThought is intended for healthcare professionals practicing medicine outside of the United States.

Released: October 08, 2021

Expiration: October 07, 2022

No longer available for credit.

Share

Faculty

Bernard Doger de Spéville

Bernard Doger de Spéville, MD, PhD

Medical Oncology
START-Madrid, Early Phase Clinical Trials Unit
Hospital Fundación Jiménez Diaz
Madrid, Spain

Prof Isabelle Ray-Coquard

Prof Isabelle Ray-Coquard, MD, PhD

President of the Gineco Group
Centre Leon Bérard
Laboratoire RESHAPE u1290
Université Claude Bernard Lyon Est
Lyon, France

Supporters

This educational activity is supported by an educational grant from

GlaxoSmithKline

Faculty Disclosure

Primary Author

Bernard Doger de Spéville, MD, PhD

Medical Oncology
START-Madrid, Early Phase Clinical Trials Unit
Hospital Fundación Jiménez Diaz
Madrid, Spain

Bernard Doger de Spéville, MD, PhD, has no relevant conflicts of interest to report.

Prof Isabelle Ray-Coquard, MD, PhD

President of the Gineco Group
Centre Leon Bérard
Laboratoire RESHAPE u1290
Université Claude Bernard Lyon Est
Lyon, France

Prof Isabelle Ray-Coquard, MD, PhD, has disclosed that she has received consulting fees from Amgen, AstraZeneca, Clovis, Deciphera, GlaxoSmithKline, Mersana, MSD, and Roche.

Staff Disclosure

Staff

Jerfiz Constanzo, PhD, MBA

Scientific Director

Jerfiz Constanzo, PhD, MBA, has no relevant conflicts of interest to report.

Gordon Kelley,

Clinical Editor
Clinical Care Options, LLC

Gordon Kelley has no relevant conflicts of interest to report.

Kevin Obholz, PhD

Editorial Director, Hematology/Oncology

Kevin Obholz, PhD, has no relevant conflicts of interest to report.

Timothy A. Quill, PhD

Senior Managing Editor

Timothy A. Quill, PhD, has no relevant conflicts of interest to report.